PubMed HealthSearch

Biomedical subjects

P Falagiani

Publications and source records attributed to P Falagiani.

At least 19 recordsLinked to original sources

Local nasal immunotherapy in allergic rhinitis to Parietaria. A double-blind controlled study.

Preseasonal local nasal immunotherapy (LNIT) by means of an extract in macronized powder form has been studied in allergic rhinitis to parietaria. Twenty-four Parietaria-sensitive patients have been studied for 18 weeks in a double-blind controlled trial. Subjects were selected on the basis of a positive skin test, RAST and intranasal challenge to Parietaria antigen. Three eight-patient groups were randomly planned: the first group was given native Parietaria product, the second modified Parietaria product, and the third placebo. During the pollen season no difference was observed in mean weekly symptom score between the three groups, while the mean weekly medication score was significantly lower in the treated groups than the control group. Only the treated groups showed a significant increase in specific nasal threshold to Parietaria after treatment. Adverse reactions to LNIT, limited to the upper respiratory tract, occurred rarely and did not interfere with the dose schedule. This study indicates that LNIT in powder form may be a suitable alternative to the traditional subcutaneous immunotherapy in terms of clinical efficacy and safety.

Adolescent

Allergenic fragments in Parietaria judaica pollen extract.

High-performance ion-exchange chromatography and immunoaffinity chromatography suggest that Par jI, the principal allergenic component of Parietaria judaica pollen, is a very unstable molecule, which tends to fragment in solution. Several fragments were obtained from Par jI and some of them show positivity toward the anti-Par jI monoclonal antibody, suggesting that they retain the entire structure of the allergenic determinant. These fragments could be the target for sequence and conformation studies.

Allergens

Detection of IgE-binding activity in serum after intranasal treatment of normal rabbits with P. judaica extract.

Local intranasal immunotherapy relieves the allergic symptoms of rhinitic patients but little is known about the absorption and distribution of inhaled allergens in the body. The aim of this study was to establish whether allergenic proteins are able to reach the bloodstream by penetrating through the nasal mucosa when aqueous P. judaica extract was administered into the nostrils of normal rabbits. Optimal conditions for a sensitive modified RAST (immunocapture RAST) were set up and the method was used to detect clinically relevant allergenic activity in the systemic circulation. The kinetic profile after intranasal treatment was compared with the profile after intravenous injection of the allergenic extract. The findings are discussed in relation to the mechanism by which local immunotherapy acts.

Administration, Intranasal

Inhaled furosemide prevents both the bronchoconstriction and the increase in neutrophil chemotactic activity induced by ultrasonic "fog" of distilled water in asthmatics.

Inhaled furosemide has been shown to prevent bronchoconstriction induced by inhalation of ultrasonic nebulization of distilled water (UNDW) in bronchial asthma. To evaluate whether inhaled furosemide also prevents the increase in serum neutrophil chemotactic activity (NCA) observed during UNDW bronchoconstriction, we measured NCA during UNDW challenge without (control) and immediately after inhalation of furosemide (40 mg) or placebo (saline) in 10 asthmatics responsive to UNDW, in a randomized, double-blind study. NCA was assessed by measuring the maximal distance reached by neutrophils in a filter when challenged with the subject serum in a Boyden chamber ("leading front"). UNDW inhalation produced a significant increase in NCA in each subject. Gel filtration chromatography on S400 column indicated that the NCA released were 600 to 700 kD. Saline had no effect on bronchoconstriction nor on NCA increase induced by UNDW in nine patients. Furosemide did not change baseline FEV1, but it prevented bronchoconstriction and NCA increase in nine patients. In the whole group the maximal decrease in FEV1 after UNDW was -31.1%, SEM 4.7 after saline and -7.5%, SEM 5.2 after furosemide, p less than 0.001, the maximal increase in NCA after UNDW was +52.9%, SEM 9.2 after saline and +3.8%, SEM 3.1 after furosemide, p = 0.001. These results indicate that inhaled furosemide prevents both the bronchoconstriction and the NCA increase induced by UNDW inhalation in most asthmatic patients. This finding adds support to the suggestion that furosemide acts on mast cells.

Administration, Inhalation

Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production.

A large series of T cell clones (TCC) specific for purified protein derivative (PPD) of Mycobacterium tuberculosis (total 60) or Toxocara canis excretory/secretory (TES) antigen (total 69) were established from the peripheral blood of two healthy individuals and analyzed for their profile of cytokine production in response to stimulation with either the specific antigen or the polyclonal activator phorbol myristate acetate plus anti-CD3 antibody. Under both these experimental conditions, the great majority of PPD-specific TCC secreted IL-2 and IFN-gamma but not, or limited amounts of, IL-4 and IL-5. In contrast, most TES-specific TCC secreted IL-4 and IL-5 but not, or limited amounts of, IL-2 and IFN-gamma. PPD-specific TCC that failed to secrete IL-4 and IL-5, and TES-specific TCC that failed to secrete IL-2 and IFN-gamma, were found to lack transcripts for IL-4 and IL-5, or for IL-2 and IFN-gamma, respectively. During the course of the study, over a 6-mo period, the functional phenotype of both TES- and PPD-specific TCC was repeatedly assessed and remained constant. These data demonstrate that T cells with stable Th1 or Th2 functional pattern exist not only in mice but also in humans and suggest that in the course of natural immunization certain infectious agents preferentially expand T cell subsets with stable and definite profile of cytokine production.

Adult

Purification of Parj I, a major allergen from Parietaria, judaica pollen.

A major allergen, the Parj I, was purified to homogeneity from Parietaria judaica pollen by means of ultrafiltration dialysis, preparative polyacrylamide gel chromatography and affinity chromatography through a column of Sepharose-monoclonal antibody specific for Parj I. The homogeneity of the Parj I was assessed by one single arc of immunoprecipitation both in cross immunoelectrophoresis (CIE) and crossed radioimmunoelectrophoresis, by one single band of radiostaining after a sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transfer to nitrocellulose and by one single peak after a size exclusion chromatography on high-performance liquid chromatography (HPLC). The homogeneity was further supported by crossed Laurell immunoelectrophoretic analysis, in that only one arc of precipitation was magnified in CIE after addition of the purified allergen. The purified Parj I allergen was capable of interacting in vitro with 70% of the human IgE specific for a crude P. judaica extract, as determined by radioallergosorbent test inhibition. The purified Parj I was capable of inducing positive reactions in vivo in skin prick tests, and of inducing release of histamine from blood containing basophils as determined by a histamine release assay. The amino acid analysis of the Parj I showed 118 amino acid residues per monomer analyzed and, among other residues, three methionine residues were detected. The molecular weight of the Parj I estimated by HPLC and amino acid composition was 26 kilodaltons.

Allergens

Analysis of allergenic components of a Parietaria judaica pollen extract by chromatographic methods for the evaluation of purification procedures.

Size-exclusion and ion-exchange high-performance liquid chromatography were used to monitor the presence of polymeric aggregates and of families of allergens of similar isoelectric point in Parietaria judaica pollen extracts. A radio-allergo-sorbent test and chromatofocusing were used for the analysis of individual fractions. This allows the detection of two groups of allergens, having pI of 4.7 and greater than 5.7, respectively, and shows the effect of dialysis or ultrafiltration on the distribution of allergens.

Allergens

Antigens of Euparipha pisana (snail). I. Identification of allergens by means of in vivo and in vitro analysis.

The data obtained in this study suggest that eating Euparipha pisana (snail), a common food in Mediterranean countries, could give serious allergic reaction such as asthma. We describe here the identification and partial characterization of allergenic molecules form this new source. An aqueous extract of snail was obtained by homogenization in distilled water, centrifugation, dialysis and defatting with ethyl ether. Skin prick test (SPT) performed with the snail extract on 70 subjects allergic to the more common allergens of the Mediterranean area gave a SPT positivity in 61% of the subjects tested, with a mean value of histamine-equivalent prick (HEP) equal to 0.81 +/- 0.25 (n = 43), while no SPT-snail-positive reactions were obtained by using the same extract on 30 not allergic subjects. To ascertain if such a sensitivity was IgE-mediated, sera from SPT-snail-positive subjects were analyzed by RAST, coupling the snail extract to polystyrene balls and to paper discs. 19% of the sera tested were RAST-positive, mean value of binding 4.8 +/- 2.8% (n = 13), while when using sera from SPT-snail-negative subjects, the RAST mean value was 0.49 +/- 0.18% (n = 27). Histamine release (HR) was also performed. Basophils prepared from SPT-snail-positive subjects were incubated with a snail extract. All of the SPT-snail-positive subjects gave a significant value of HR, mean value 21.8 +/- 7% using 1 micrograms of snail extract (n = 16), while 1.41 +/- 1.1% (n = 10) was the mean value obtained when SPT-snail-negative subjects were analyzed.(ABSTRACT TRUNCATED AT 250 WORDS)

Allergens

IgE and IgG antibodies in Toxocara canis infection. A clinical evaluation.

The relationship between IgE and IgG antibodies against the metabolic exoantigen of Toxocara canis (TEX antigen) in sera of selected patients with the ocular and visceral form of the disease have been investigated. The specificity and sensitivity of the TEX antigen employed in immunoenzymatic and radioimmunologic assays have been verified. Six hundred and forty-one sera from healthy donors were tested as controls. Our data emphasize the importance of IgE antibodies to ocular larva migrans syndrome and suggest that they play a significant role as a marker of infection. In the visceral form, IgG antibodies seem to mask the presence of IgE by a competitive mechanism toward the same epitopes of the parasite. In fact, IgE antibody titers increase after depletion of IgG from serum.

Antibodies, Helminth

[Inhalation allergy to fly larva. A clinical case].

The authors describe a clinical case of rhinitis and asthma in an angler after exposure to antigenic material released from larvae of fly, commonly used by anglers as bait. The common names of these larvae are "blue bottle", "green bottle" and "grey bottle". The patient was usually in good health, free from allergic diseases and free from asthmatic attacks when far from exposure to the baits. Spirometric evaluation revealed a fall of 21% in VEMS after challenge with antigen. Skin test (prick) with an extract obtained from the baits and RAST were strongly positive. By avoidance of exposure to antigen obtained changing type of bait, the asthmatic attacks completely disappeared. The authors discuss the clinical, diagnostic and preventive aspects of this allergic syndrome, and deal with the taxonomy of the insect.

Adult

RAST and ELISA in three autochthonous parasitic infections in Italy: toxocariasis, hydatidosis and fascioliasis.

Toxocariasis, Hydatidosis and Fascioliasis are common autochthonous parasitic infections in Italy. RAST and ELISA have been evaluated for serological diagnosis. Eight sera from Toxocariasis, fifty from Hydatidosis and two from Fascioliasis have been examined. Excretory/secretory antigen has been employed for the serology of Toxocariasis, hydatic fluid for Hydatidosis and embryonated-eggs antigen for Fascioliasis. The RAST resulted positive in 4/5 cases of the visceral form of Toxocariasis and 3/3 in the ocular form, in 2/2 cases of Fascioliasis and 27/50 of Hydatidosis. The ELISA resulted positive respectively in 5/5, 3/3, 2/2, and 19/50 cases. The sensitivity and specificity of the tests employed have been proved.

Animals

Enzyme immunoassay (ELISA) for the detection of specific IgG antibodies to Toxocara canis ES antigens.

This paper reports the development of an enzyme-immunosorbent assay for the detection in human serum of specific IgG against excretory/secretory antigens of second stage Toxocara canis larvae. Similar tests have been already used in several countries for clinical and epidemiological purposes on human Toxocariasis and currently represent the only specific means for the serological diagnosis of this parasitic disease. Specificity and sensitivity have been proved and original data on the epidemiological setting of Toxocara infection in Northern Italy are given.

Adult

Simplified spinhaler method for antigen-specific bronchoprovocation in children with bronchial asthma. I.

Specific bronchial challenge has been performed using a micronized, freeze-dried allergen extract of D. pteronyssinus administered as a powder at increasing concentrations (0, 50, 100, 200, 400, 600, 800, and 1,000 Allergenic Units) by a cromolyn spinhaler delivery system. The test was performed in ten asthmatic children with house mite D. pteronyssinus skin test and RAST positivity and in six non-allergic asthmatic children. A positive early reaction to bronchial challenge occurred in eight out of ten allergic children. A ninth child of this allergic group presented only the late reaction. Five patients of the control group (skin test and RAST negative for D. pteronyssinus had negative results while one child had a positive response both with early and late reactions. A significant increase in methacholine sensitivity was observed in the allergic group the day following the specific challenge. The modified spinhaler procedure (Hypoinhal, Lofarma) used for specific bronchial challenge showed a good correlation with skin test and RAST positivity in patients as well as in the control population. The method provides advantages of simplicity, ease of performance and cost effectiveness.

Administration, Intranasal